https://orcid.org/0000-0002-6985-3509
References
- Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451–458.
- Melnick A, Licht JD. Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93(10):3167–3215.
- Andreeff M, Jiang S, Zhang X, et al. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia. 1999;13(11):1881–1892.
- Li D, Liu S, Chen L, et al. All-trans retinoic acid enhances the anti-leukemia effect of venetoclax on acute myeloid leukemia cells. Blood. 2019;134(Supplement_1):5055–5055.
- Buschner G, Feuerecker B, Spinner S, et al. Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis. Leuk Lymphoma. 2021;62(3):630–639.
- Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435(7042):677–681.
- Vogler M, Hamali HA, Sun XM, et al. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145–7154.
- Jenal M, Batliner J, Reddy VA, et al. The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia. 2010;24(5):1073–1076.
- Liu CY, Chuang PI, Chou CL, et al. Cytoprotective response of A1, a Bcl-2 homologue expressed in mature human neutrophils and promyelocytic HL-60 cells, to oxidant stress-induced cell death. J Biomed Sci. 2004;11(2):214–227.
- Xia L, Wurmbach E, Waxman S, et al. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia. 2006;20(6):1009–1016.
- Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157–162.
- Küley-Bagheri Y, Kreuzer KA, Monsef I, et al. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)). Cochrane Database Syst Rev. 2018;8:CD011960